Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Mayo Clinic
The diagnostics industry could benefit from a greater focus on real-world evidence linked to the COVID-19 pandemic, according to experts from the US FDA and industry.
Tech Transfer Roundup: Anixa Thinks Cleveland Clinic IP Offers Potential In Triple-Negative Breast Cancer
Anixa obtains cancer vaccine targeted to proteins common in breast cancer from Cleveland Clinic. Arxx licenses Cancer Research UK antibody that targets tumor microenvironment.
Gene-editing focused start-ups Beam Therapeutics, Gracell, Snipr Biome and Precision Biosciences raised a total of $310m in financings in February and March. For other recent venture funding deals...
Five-year collaboration will analyze data from thousands of cancer patients to optimize immunotherapy treatment and develop PET imaging tracers to stratify clinical trial participants. Also, MD Anderson starts 2019 with three new agreements.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Mayo Clinic Laboratories
- Mayo Medical Laboratories